Skip to content

NxStage PureFlow B Solution RFP-455

by NxStage Medical, Inc.

NxStage PureFlow B Solution RFP-455 is a haemodialysis dialysate solution (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by NxStage Medical, Inc., listed in FDA GUDID since 1 Sep 2015 (UDI-DI M535RFP4550), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberM535RFP4550 UDI-DI Date1 Sep 2015ListedStatusListed GUDID: in commercial distribution

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
Labelled as not made with natural rubber latex
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
NxStage PureFlow B Solution
Generic name
Haemodialysis dialysate solution
Model / reference
RFP-455
Primary DI / UDI-DI
M535RFP4550
FDA product code
KPO
GMDN term
Haemodialysis dialysate solution
Device class
Class II
Regulation number
876.5820
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from NxStage Medical, Inc.

See all devices from NxStage Medical, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)